KnightByrd Nexus
← The full survey

Ichnos · industry survey

Can you advertise compounding pharmacy?

Yes — in 38 places we have confirmed, out of 328examined. Not on the major platforms: compounded preparations may not be advertised as though they were approved drugs, and pharmacy advertising requires certification the platforms grant slowly and revoke quickly.

That is a fact about the platform’s category rules, not a finding about any business in it. The audience has not gone anywhere — it simply gathers somewhere the ad platforms do not sell access to. Each of the 38 says so in its own words, on its own page, and we quote the sentence — so the answer is checkable rather than asserted.

328
Places found
Publications, associations, forums and directories where this industry’s own language is actually spoken.
38
Confirmed open
These say in their own words that an outsider may take part. We quote the sentence, so you can judge it rather than take ours.
31
You can simply buy
Advertising, sponsored placement or event presence — a budget and a decision, not an application.
$44K–$368K
Worth, per year
Estimated value of the placement you could buy here. Banded from what each destination offers — not from rate cards we do not hold.

What these places let an outsider do

Almost none of it is guest posting. For an industry that cannot buy ads on the major platforms, an advertising page on a trade publication is not a lesser option — it is the channel.

Buy advertising They sell placement to outside businesses.15
Sponsor or exhibit Event presence sold to the trade.13
Join as a member Membership open to businesses in the category.9
Send a press release They publish announcements from the trade.8
Contribute an article They accept contributed or guest articles.4
Place sponsored content Paid editorial, disclosed as such.3

Why the ordinary channels are closed

Most categories are locked out by one of these. Compounding pharmacy carries both.

Regulation

Restricted by a regulator, not just a platform

A public body governs what may be claimed, to whom, and with what disclosure. This one does not go away by changing channel — the same rules apply to a trade publication, a conference talk and a mailing. What changes off-platform is that the channel will actually carry the message once it is compliant.

Platform policy

Gated behind certification

Advertising is technically permitted but only after an approval process — often slow, often expensive, and frequently limited by state or by what may be said once approved. The gate is real rather than nominal: many businesses in the category never clear it, and those that do still cannot say the thing that would make the advertisement work.

Where to start, and why in this order

Ordered by what you can act on soonest, not by what we found most of. A route that takes a rate card and a date beats one that takes a relationship, when the question is what to do on Monday.

  1. 1
    Buy advertising 15 places

    15 of the 38 open destinations in compounding pharmacy sell placement outright, which makes this the fastest route in the category: there is nothing to negotiate and nobody to persuade, only a rate card and a date. 15 is enough to test two or three and keep the ones that return, but not enough to treat as a channel on its own.

  2. 2
    Send a press release 8 places

    Free, and worth exactly as much as the news in it. 8 destinations publish announcements from compounding pharmacy. A category wire will run a genuine announcement — a licence, a location, a hire — and will ignore a rewritten product page.

  3. 3
    Place sponsored content 3 places

    Slower and more expensive than a banner, and worth more: it carries the publication's context rather than sitting beside it. 3 destinations in compounding pharmacy will take it. Disclosure is mandatory and is not a drawback — an audience that knows what it is reading trusts the publication that told them, which in a category the platforms have already refused is worth more than the impression.

  4. 4
    Sponsor or exhibit 13 places

    The most expensive route and often the highest intent, because the people in the room chose to be there. Compounding pharmacy has 13 destinations selling event presence. Book the prospectus early; in a trade calendar this size the good slots go a long way ahead.

  5. 5
    Join as a member 9 places

    Slowest to pay off and hardest for a competitor to replicate. 9 bodies accept members from compounding pharmacy, and membership usually unlocks the newsletter, the directory and the event at member rates — so treat each one as the key to three routes rather than as one on its own. In a category the platforms refuse, standing is the asset that cannot be switched off by a policy change.

  6. 6
    Contribute an article 4 places

    Requires something to say that somebody working in compounding pharmacy would not already know. 4 destinations accept contributed articles. Where it works it works well: a contributed piece carries a byline and a link and stays indexed for years, which is the one form of presence here that appreciates.

Start with these — free, no account

20 of the confirmed-open destinations for compounding pharmacy accept outside participation without charging for it. No budget, no ad account, no permission from a platform. Open any one and look for the way in.

A further 31 destinations sell access outright — advertising, sponsored placement or event presence. Those need a budget and a decision rather than an application, and they come with the rate-card route and the sentence from each destination’s own policy page in the paid map.

Get the compounding pharmacy map

Every one of the 38 confirmed-open places, with what each lets you do and the sentence on their own site that says so. One industry, one payment, delivered as a file you keep. See a sample map first — it is a real one, with the identities withheld after the first three in each section.

$497one-off · 38 confirmed-open places, each with the sentence from their own site. Delivered immediately, no account.Against $44K–$368K a year of purchasable access
Buy this map — $497

A map is a dated reading, and policies move. Kept current is $997 a year — the same map plus quarterly re-verification of every route in it and the log of what opened, closed or changed terms in compounding pharmacy. Agencies running several restricted categories take every industry for $2,997 a year. Compare all four.

Tell us your industry and we will send what the survey holds for it, what it costs, and what it does not cover.

Goes straight to David. No list, no autoresponder — and we never contact anyone who did not write to us first.

Questions people in this category actually ask

Answered plainly, including the one where the honest answer is “don’t”.

Why was my compounding pharmacy ad account banned or rejected?

Almost always for the category rather than for anything specific to your business. The major platforms apply their rules to compounding pharmacy as a class, so a licensed, compliant operator is refused on the same footing as one that is not. It is a fact about their category rules, not a finding about you — which is also why appealing rarely works: there is nothing about your individual account to reconsider.

Can I get around it with a second account or a different compounding pharmacy business name?

Do not. This is the advice most readily available elsewhere and it is the advice that ends businesses. Platforms link accounts by payment method, device, IP, business registration and staff logins; a second account discovered is usually a permanent termination of everything connected to it, rather than the suspension you started with. It is a particularly bad trade in compounding pharmacy, where 38 destinations already publish a way in and 31 of them will take your money today — you would be risking the business to avoid an afternoon's work. The route out of a category ban is a different channel, not a different login.

Where can compounding pharmacy advertise instead?

Where the industry already gathers. We have mapped 328 such places — trade publications, associations, professional forums and directories — and 38 of them publish a way in for outside businesses, read off their own pages and quoted. 31 of those sell advertising, sponsored placement or event presence outright, which means a budget and a decision rather than an application.

Is this just a list of compounding pharmacy websites?

No, and the difference is the whole product. A list of places your audience gathers is a reading list. What makes it a map is the permission column: for each place, whether it publishes a way in, what kind, and the sentence on their own site that says so. We read 328 destinations serving compounding pharmacy to find the 38 that say yes — and the 290 that say nothing either way are the reason a list is not enough. Anyone can assemble the list; the reading is the work.

Industries in the same position

Shut out the same way compounding pharmacy is — same kind of refusal, so the same shape of answer.

Tax resolution and IRS debt57 confirmed open of 310 mappedDigital mental health56 confirmed open of 366 mappedPrecious metals and self-directed retirement56 confirmed open of 394 mappedBariatric and weight-loss surgery55 confirmed open of 380 mappedDebt relief and credit repair55 confirmed open of 365 mappedCosmetic and plastic surgery53 confirmed open of 344 mapped

How this was assembled

Stage one

Learn the language

The vocabulary this industry uses among itself — its regulators, licences, statutes and trade bodies. Say them correctly and you are inside the trade.

Stage two

Find where it is spoken

The publications, associations and forums where that vocabulary actually appears. Not where an audience might be — where its language demonstrably is.

Stage three

Check the way in

Whether each place accepts anything from outside, read from its own advertising or submissions page and quoted verbatim.

See all industries in the survey →